Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Department of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Eye (Lond). 2021 Aug;35(8):2260-2269. doi: 10.1038/s41433-020-01240-z. Epub 2020 Oct 30.
To evaluate the potential of an integrated virtual medical retina clinic in secondary care for diabetic patients screened and referred by the UK National Diabetic Eye Screening Program (DESP).
This retrospective cohort study included diabetic patients referred by the DESP to either a virtual or a traditional doctor's appointment (face-to-face, F2F) at the Moorfields Eye Hospital NHS Foundation Trust (London, UK) between January 2015 and December 2018. The primary outcome was the proportion of patients that qualified for a virtual-clinic appointment according to hospital guidance. Secondary outcomes included the rate of attendance, mean time from DESP referral to initial hospital appointment, mean time-to-discharge and -to-treatment of either panretinal photocoagulation or intravitreal injection of anti-vascular endothelial growth factor.
We included 12,563 patients in this study. While 8833 patients (70.7%) would have qualified for a virtual appointment according to local triage guidance, only 2306 (18.4%) were referred to a virtual consultation due to capacity constraints. For routine referrals, mean time to the first hospital appointment was 66.9 days with a standard deviation of ±35.9 and 80.9 ± 44.4 days for a virtual and a F2F consultation, respectively. The mean time from referral to discharge to community was 71.7 ± 30.8 and 86.3 ± 37.0 days for a virtual and a F2F consultation, respectively. We did not observe a statistically significant difference in the mean time-to-treatment in the sub-cohort that required intravitreal therapy for maculopathy (virtual clinics: 220.7 ± 84.8; F2F: 178.0 days ± 80.7; p value > 0.05). Moreover, we observed a non-inferior attendance rate in virtual as compared to F2F clinics.
A significant proportion of diabetic patients referred to a F2F clinic could initially be managed in a virtual clinic. Increasing the adoption of virtual clinics in the management of diabetic patients that do not need long-term management or monitoring in secondary services may help alleviate service demands without diminishing quality of clinical care. Collectively, our analyses suggest that virtual consultations are a faster and clinically appropriate alternative for a substantial proportion of diabetic patients.
评估在英国国家糖尿病眼病筛查计划(DESP)筛查和转诊的基础上,二级保健中综合虚拟医疗视网膜诊所对糖尿病患者的潜在应用。
本回顾性队列研究纳入了 2015 年 1 月至 2018 年 12 月期间,通过 DESP 转诊至 Moorfields Eye Hospital NHS 基金会信托(伦敦,英国)接受虚拟或传统医生预约(面对面,F2F)的糖尿病患者。主要结局是根据医院指南,有多少患者符合虚拟诊所预约条件。次要结局包括就诊率、从 DESP 转诊至首次医院预约的平均时间、全视网膜光凝或玻璃体内注射抗血管内皮生长因子的平均释放和治疗时间。
本研究共纳入 12563 例患者。尽管根据当地分诊指南,8833 例(70.7%)患者符合虚拟预约条件,但由于容量限制,仅有 2306 例(18.4%)患者被转诊至虚拟咨询。对于常规转诊,首次医院预约的平均时间为 66.9 天,标准差为±35.9;虚拟和 F2F 咨询的平均时间分别为 80.9 ± 44.4 天。从转诊到社区的平均释放时间为 71.7 ± 30.8 天和 86.3 ± 37.0 天,分别为虚拟和 F2F 咨询。我们没有观察到需要黄斑病变玻璃体内治疗的亚组患者在治疗时间上的统计学显著差异(虚拟诊所:220.7 ± 84.8 天;F2F:178.0 天±80.7;p 值>0.05)。此外,我们观察到虚拟诊所的就诊率高于 F2F 诊所。
转诊至 F2F 诊所的糖尿病患者中有很大一部分可最初在虚拟诊所中得到管理。在二级服务中,增加对不需要长期管理或监测的糖尿病患者进行虚拟诊所管理的采用,可能有助于缓解服务需求,而不会降低临床护理质量。总的来说,我们的分析表明,虚拟咨询是相当一部分糖尿病患者更快、更合适的选择。